Navigation Links
Tumor cells' inner workings predict cancer progression
Date:7/27/2012

Using a new assay method to study tumor cells, researchers at the University of California, San Diego School of Medicine and UC San Diego Moores Cancer Center have found evidence of clonal evolution in chronic lymphocytic leukemia (CLL). The assay method distinguishes features of leukemia cells that indicate whether the disease will be aggressive or slow-moving, a key factor in when and how patients are treated.

The findings are published in the July 26, 2012 First Edition online issue of Blood.

The progression of CLL is highly variable, dependent upon the rate and effects of accumulating monoclonal B cells in the blood, marrow, and lymphoid tissues. Some patients are symptom-free for years and do not require treatment, which involves the use of drugs that can cause significant side effects and are not curative. In other patients, however, CLL is relatively aggressive and demands therapeutic intervention soon after diagnosis.

"Our study shows that there may not be a sharp dividing line between the more aggressive and less aggressive forms of CLL," said Thomas J. Kipps, MD, PhD, Evelyn and Edwin Tasch Chair in Cancer Research and senior author of the study. "Instead, it seems that over time the leukemia cells of patients with indolent disease begin to use genes similar to those that are generally used by CLL cells of patients with aggressive disease. In other words, prior to requiring therapy, the patterns of genes expressed by CLL cells appear to converge, regardless of whether or not the patient had aggressive versus indolent disease at diagnosis."

Existing markers for aggressive or indolent disease are mostly fixed and have declining predictive value the longer the patient is from his or her initial diagnosis. When the blood sample is collected, these markers cannot reliably predict whether a CLL patient will need therapy soon, particularly when the patient has had the diagnosis of CLL for many years.


'/>"/>

Contact: Scott LaFee
slafee@ucsd.edu
619-543-6163
University of California - San Diego
Source:Eurekalert  

Page: 1 2 3

Related medicine news :

1. Genome analysis of brain tumors showing the way to new treatment strategies
2. How the fluid between cells affects tumors
3. Researchers study vaccine as potential weapon against aggressive brain tumors
4. Neural precursor cells induce cell death in certain brain tumors
5. Genetic mutations that cause common childhood brain tumors identified
6. Study shows colon and rectal tumors constitute a single type of cancer
7. How tumor cells create their own pathways
8. Drug from Mediterranean weed kills tumor cells in mice
9. Pediatric tumors traced to stem cells in developing brain​​
10. Skin contact breast tumor detection
11. Specialized MRI scans assess value of anti-cancer chemotherapy long before tumors shown to shrink
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Tumor cells' inner workings predict cancer progression
(Date:9/23/2014)... 2014 What: Rutgers Presbyterian Church, ... Side that embodies the inclusion and diversity of ... and the Ecological Crisis, a public lecture led ... Emerita of Old Testament at Louisville Presbyterian Seminary. ... that lends insight into current ecological problems, including ...
(Date:9/23/2014)... benefits of preventing a reduction in the rates ... today by the American College of Physicians (ACP). ... Medicaid Primary Care Pay Parity Program: Unless Congress ... Care Will Expire," explains why it is critical ... pediatricians (and their related subspecialists), family physicians, and ...
(Date:9/23/2014)... Singapore (PRWEB) September 23, 2014 ... aesthetic clinics in Singapore and Malaysia providing advanced ... revolutionary BB powder to its impressive skin care ... strengthen the skin’s defences against the evil forces ... a healthy glow simultaneously, this new addition is ...
(Date:9/23/2014)... TUESDAY, Sept. 23, 2014 (HealthDay News) -- The ... million in additional funding in scientific trials to ... and clinical studies. The supplemental monies were ... fields, including basic immunology, cardiovascular physiology, neural circuitry, ... Sept. 23. "This funding strategy demonstrates our ...
(Date:9/23/2014)... Karl Klose, professor of biology and a researcher in ... teamed up with researchers at Ruhr University in Bochum, ... Their findings were released this week in an article ... of Sciences . , Cholera is an acute infection ... contaminated with the bacterium Vibrio cholerae . An ...
Breaking Medicine News(10 mins):Health News:Inhabiting Eden: Christians, Scripture, and the Ecological Crisis – Public Lecture to Discuss Faith-Based Environmentalism 2Health News:Unless Congress acts, patients may soon lose access to primary care 2Health News:Unless Congress acts, patients may soon lose access to primary care 3Health News:The Sloane Clinic™ introduces a revolutionary BB powder to its impressive skin care repertoire 2Health News:The Sloane Clinic™ introduces a revolutionary BB powder to its impressive skin care repertoire 3Health News:The Sloane Clinic™ introduces a revolutionary BB powder to its impressive skin care repertoire 4Health News:NIH Adds $10M to Encourage Gender Balance in Clinical Trials 2Health News:UTSA microbiologists discover regulatory thermometer that controls cholera 2
... at the University of Cambridge claim to have identified four ... ,They made this breakthrough by using the new trawling ... simultaneously instead of one by one. ,They believe ... 12 to 15 years, in which the inherited risk of ...
... by a team of researchers led by Dr Peter Burney ... ,As part of the study, researchers analysed schoolchildren who were ... ,Researchers asked their parents about their kids fruit consumption ... study found that although there was no connection between apple ...
... has been reduced to begging for survival in Orissa after villagers ... can be passed on by social contact. ,And ... Sukanti (name changed), only 30 years of age, and her younger ... Cuttack district, 50 km from here. ,Life became hell ...
... more likely to later develop Alzheimer's disease than people ... study published in the May 29, 2007, issue of ... Neurology. ,The study, which is part of ... with an average age of 79. Blood tests determined ...
... public health problem in many developing countries, frequently ... survive. Often undiagnosed or untreated, syphilis is passed from ... in prenatal programs to prevent the spread of HIV. ... College and the Groupe Haitien d'Etude du Sarcome de ...
... change policy, ministers from Asia - including India's - met ... for talks on world crises. ,The two-day Asia-Europe ... division between European countries seeking deep cuts in world carbon-dioxide ... global warming. ASEM is held every two years. India, Pakistan ...
Cached Medicine News:Health News:Scientists Identify Four Genes That Raise the Risk of Breast Cancer 2Health News:Apple Juice may Help to Keep Childhood Asthma at Bay 2Health News:Rapid Syphilis Could Prevent Congenital Disease and Stillbirths in Haiti 2Health News:Rapid Syphilis Could Prevent Congenital Disease and Stillbirths in Haiti 3Health News:EU Pushes Asian Nations on Climate Change Goals 2
(Date:9/23/2014)... , Sept. 23, 2014 Cerevast Therapeutics ... today the outcome of the first interim analysis ... the Company,s proprietary Clotbust ER TM ... ischemic stroke. The independent Data Safety Monitoring Board ... planned. "Clearing the pre-specified futility threshold ...
(Date:9/23/2014)... therapy recently began in the Czech Republic for ... the United States draws to a close today ... days to live now looks forward to his first day of kindergarten. ... complained of a headache in June, it was the first ... 23, when he completes proton radiation therapy for a brain ...
(Date:9/23/2014)... Sept. 23, 2014 CASI Pharmaceuticals, Inc. (Nasdaq: ... the acquisition, development and commercialization of innovative therapeutics addressing ... market with a primary focus on China ... Shrotriya , MD, Chairman and Chief Executive Officer of ... appointment was made in connection with the recently announced ...
Breaking Medicine Technology:Cerevast Therapeutics Announces Outcome of First Interim Analysis of Phase 3 CLOTBUSTER Trial for the Treatment of Acute Ischemic Stroke 2Cerevast Therapeutics Announces Outcome of First Interim Analysis of Phase 3 CLOTBUSTER Trial for the Treatment of Acute Ischemic Stroke 35-Year-Old Brain Cancer Patient Completes Proton Therapy, Awaits Kindergarten 25-Year-Old Brain Cancer Patient Completes Proton Therapy, Awaits Kindergarten 35-Year-Old Brain Cancer Patient Completes Proton Therapy, Awaits Kindergarten 4CASI Pharmaceuticals Announces Appointment Of Rajesh C. Shrotriya, MD To The Board Of Directors 2CASI Pharmaceuticals Announces Appointment Of Rajesh C. Shrotriya, MD To The Board Of Directors 3CASI Pharmaceuticals Announces Appointment Of Rajesh C. Shrotriya, MD To The Board Of Directors 4
... SAN DIEGO, May 7, 2012  Halozyme Therapeutics, Inc. (NASDAQ: ... the quarter ended March 31, 2012. (Logo:  ... milestone in the first quarter with the European regulatory ... Roche," said Gregory I. Frost, Ph.D., President and Chief ...
... May 7, 2012 The National Council on ... customized, online educational modules to promote safe use ... in America, acetaminophen, is found in more than ... relievers, fever reducers, and sleep aids as well ...
Cached Medicine Technology:Halozyme Reports First Quarter 2012 Financial Results 2Halozyme Reports First Quarter 2012 Financial Results 3Halozyme Reports First Quarter 2012 Financial Results 4Halozyme Reports First Quarter 2012 Financial Results 5Halozyme Reports First Quarter 2012 Financial Results 6Safe Use of Acetaminophen 2Safe Use of Acetaminophen 3Safe Use of Acetaminophen 4
... manufactures slides that are compatible with multichannel ... the number of pipetting steps required to ... on the slides. Ask Immuno Concepts for ... slides. These slide formats are noted with ...
... ANA uses a patented HEp-2 cell line ... the sensitivity to SS-A/Ro autoantibodies, without affecting ... studies have been published worldwide on the ... to SS-A/Ro autoantibodies when used in place ...
... and ENA assays can be used ... antinuclear antibodies, which are associated with ... Systemic lupus erythematosus (Lupus), Sjgren's syndrome, ... sclerosis, scleroderma, polymyositis, dermatomyositis, and Raynaud's ...
... assays can be used to screen ... which are associated with various systemic ... erythematosus (Lupus), Sjgren's syndrome, mixed connective ... polymyositis, dermatomyositis, and Raynaud's phenomenon. They ...
Medicine Products: